Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319294406> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4319294406 endingPage "617" @default.
- W4319294406 startingPage "613" @default.
- W4319294406 abstract "Minor adverse event following immunizations (AEFIs) are often underreported and self-treated. This study aimed to collect information regarding any and every probable adverse event experienced by the recipient of Covishield vaccine up to 10 days following the first and second dose of vaccine. To find the incidence of minor adverse events following Covishield vaccination; draw an association between adverse events and individuals' demographic factors and comorbidities; and report new adverse events, if any.A descriptive observational study was conducted among 409 participants randomly sampled from the Vaccination Centre at a Tertiary Care Hospital, Mumbai. Participants were followed up post their first and second doses to enquire about adverse events.Most commonly reported adverse events included injection site pain, tenderness, chills, fatigue, fever, and myalgia. Females reported more adverse events compared to men (p < 0.05). Younger individuals (18-24) experienced adverse events more as compared to individuals above 40 years of age (p < 0.005). Reported adverse events were lesser after the second dose in comparison with the first dose. Few participants reported dysgeusia.Covishield vaccination has a mild AEFI profile, most commonly: injection site pain, tenderness, chills, and fatigue. It is hoped that the findings of this study will dispel anxiety around the adverse events of vaccination and reduce any persisting vaccine hesitancy. Effective communication with the population on vaccination will enable individuals to make educated and informed decisions." @default.
- W4319294406 created "2023-02-07" @default.
- W4319294406 creator A5009187620 @default.
- W4319294406 creator A5024763337 @default.
- W4319294406 creator A5026351901 @default.
- W4319294406 creator A5027869140 @default.
- W4319294406 creator A5091666127 @default.
- W4319294406 date "2023-02-07" @default.
- W4319294406 modified "2023-09-28" @default.
- W4319294406 title "Incidence of Early Adverse Events Following Covishield (ChAdOx1 nCoV-19) Vaccination: A Prospective Study." @default.
- W4319294406 cites W3147435343 @default.
- W4319294406 cites W3154615775 @default.
- W4319294406 cites W3158373340 @default.
- W4319294406 cites W3176875694 @default.
- W4319294406 cites W3186357292 @default.
- W4319294406 cites W4226310502 @default.
- W4319294406 doi "https://doi.org/10.4103/ijcm.ijcm_93_22" @default.
- W4319294406 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36742958" @default.
- W4319294406 hasPublicationYear "2023" @default.
- W4319294406 type Work @default.
- W4319294406 citedByCount "0" @default.
- W4319294406 crossrefType "journal-article" @default.
- W4319294406 hasAuthorship W4319294406A5009187620 @default.
- W4319294406 hasAuthorship W4319294406A5024763337 @default.
- W4319294406 hasAuthorship W4319294406A5026351901 @default.
- W4319294406 hasAuthorship W4319294406A5027869140 @default.
- W4319294406 hasAuthorship W4319294406A5091666127 @default.
- W4319294406 hasConcept C120665830 @default.
- W4319294406 hasConcept C121332964 @default.
- W4319294406 hasConcept C126322002 @default.
- W4319294406 hasConcept C187212893 @default.
- W4319294406 hasConcept C197934379 @default.
- W4319294406 hasConcept C203014093 @default.
- W4319294406 hasConcept C22070199 @default.
- W4319294406 hasConcept C23131810 @default.
- W4319294406 hasConcept C2777054765 @default.
- W4319294406 hasConcept C2778594517 @default.
- W4319294406 hasConcept C2778616394 @default.
- W4319294406 hasConcept C61511704 @default.
- W4319294406 hasConcept C71924100 @default.
- W4319294406 hasConceptScore W4319294406C120665830 @default.
- W4319294406 hasConceptScore W4319294406C121332964 @default.
- W4319294406 hasConceptScore W4319294406C126322002 @default.
- W4319294406 hasConceptScore W4319294406C187212893 @default.
- W4319294406 hasConceptScore W4319294406C197934379 @default.
- W4319294406 hasConceptScore W4319294406C203014093 @default.
- W4319294406 hasConceptScore W4319294406C22070199 @default.
- W4319294406 hasConceptScore W4319294406C23131810 @default.
- W4319294406 hasConceptScore W4319294406C2777054765 @default.
- W4319294406 hasConceptScore W4319294406C2778594517 @default.
- W4319294406 hasConceptScore W4319294406C2778616394 @default.
- W4319294406 hasConceptScore W4319294406C61511704 @default.
- W4319294406 hasConceptScore W4319294406C71924100 @default.
- W4319294406 hasIssue "4" @default.
- W4319294406 hasLocation W43192944061 @default.
- W4319294406 hasOpenAccess W4319294406 @default.
- W4319294406 hasPrimaryLocation W43192944061 @default.
- W4319294406 hasRelatedWork W2357423789 @default.
- W4319294406 hasRelatedWork W2581074245 @default.
- W4319294406 hasRelatedWork W3201119860 @default.
- W4319294406 hasRelatedWork W3208493119 @default.
- W4319294406 hasRelatedWork W3215733694 @default.
- W4319294406 hasRelatedWork W4200350460 @default.
- W4319294406 hasRelatedWork W4211198694 @default.
- W4319294406 hasRelatedWork W4282047692 @default.
- W4319294406 hasRelatedWork W4283518051 @default.
- W4319294406 hasRelatedWork W4284891694 @default.
- W4319294406 hasVolume "47" @default.
- W4319294406 isParatext "false" @default.
- W4319294406 isRetracted "false" @default.
- W4319294406 workType "article" @default.